[1]秦丰,任佳绪,耿雯,等.糖尿病患者血清中同型半胱氨酸水平与视网膜神经节细胞层厚度的相关性研究[J].眼科新进展,2018,38(6):542-544.[doi:10.13389/j.cnki.rao.2018.0126]
　QIN Feng,REN Jia-Xu,GENG Wen,et al.Correlation between serum homocysteine level and retinal ganglion cell layer thickness in diabetic patients[J].Recent Advances in Ophthalmology,2018,38(6):542-544.[doi:10.13389/j.cnki.rao.2018.0126]
点击复制

糖尿病患者血清中同型半胱氨酸水平与视网膜神经节细胞层厚度的相关性研究/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
38卷
期数:
2018年6期
页码:
542-544
栏目:
应用研究
出版日期:
2018-06-05

文章信息/Info

Title:
Correlation between serum homocysteine level and retinal ganglion cell layer thickness in diabetic patients
作者:
秦丰; 任佳绪; 耿雯; 徐晓鹤; 刘鹤南; 王爱媛
110004　辽宁省沈阳市，中国医科大学附属盛京医院眼科
Author(s):
QIN Feng; REN Jia-Xu; GENG Wen; XU Xiao-He; LIU He-Nan; WANG Ai-Yuan
Ophthalmology，Shengjing Hospital of China Medical University，Shenyang 110004，Liaoning Province，China
关键词:
糖尿病视网膜病变; 同型半胱氨酸; 神经节细胞层
Keywords:
diabetic retinopathy;  homocysteine;  ganglion cell layer
分类号:
R774
DOI:
10.13389/j.cnki.rao.2018.0126
文献标志码:
A
摘要:
目的　探讨2型糖尿病患者血清中同型半胱氨酸（homocysteine，Hcy）水平与视网膜神经节细胞层（ganglion cell layer，GCL）厚度之间的相关性。方法　收集2016年10月至2017年10月就诊于中国医科大学附属盛京医院的60例糖尿病患者和30人健康对照者（对照组），根据ETDRS分类将糖尿病患者分为两组：不伴眼底病变的糖尿病患者组（NDR组，n=30）和非增殖期糖尿病视网膜病变患者组（NPDR组，n=30），检测所有病例血清中Hcy水平，并使用光学相干断层扫描测量其视网膜GCL厚度。分析血清中Hcy水平和GCL厚度变化及两者之间的相关性。结果　对照组、NDR组和NPDR组血清中Hcy水平分别为（11.87±2.19）nmol·L-1、（14.87±0.42）nmol·L-1、（20.77±2.40）nmol·L-1，呈明显升高趋势，差异有统计学意义（P=0.000），而GCL厚度分别为（88.33±6.36）μm、（81.73±1.41）μm、（64.00±12.73）μm，呈明显下降趋势，差异也有统计学意义（P=0.000）。随着眼底病变进展，血清中Hcy水平增加，视网膜GCL厚度变薄；Pearson相关性分析发现，血清中Hcy水平与视网膜GCL厚度呈负相关（r=-0.908，P=0.000）。结论　糖尿病患者血清中Hcy水平增加与视网膜GCL厚度变薄相关，Hcy参与了糖尿病视网膜病变的神经退行性病变。
Abstract:
Objective　To explore the correlation between the level of serum homocysteine （Hcy） and the thickness of retinal ganglion cell layer （GCL） on optical coherence tomography （OCT） in patients with type 2 diabetes.Methods　Totally 60 diabetic patients were collected from October 2016 to October 2017 in the Shengjing Hospital of China Medical University，and they were divided into two groups：diabetic patients without retinopathy （NDR group，n=30） and non-proliferative diabetic retinopathy group （NPDR group，n=30） according to the ETDRS classification，and meanwhile additional 30 healthy subjects were enrolled as control group.The level of serum Hcy was detected，and the retinal GCL thickness was measure using OCT in all patients for the analysis of the correlation of serum Hcy level with the thickness of GCL.Results　The serum Hcy level was （11.87±2.19）nmol·L-1 in the control group，（14.87±0.42）nmol·L-1 in the NDR group and （20.77±2.40）nmol·L-1 in the NPDR group，which was significantly increased gradually，and the difference was statistically significant （P=0.000），but the thickness of GCL was （88.33±6.36）μm，（81.73±1.41）μm and （64.00±12.73）μm in the three groups，accordingly，which was decreased significantly gradually，with statistically significant difference （P=0.000）.Along with the progress of fundus lesions，the level of serum Hcy increased，but the thickness of GCL decreased，and there was a significant negative correlation of the serum Hcy level with the thickness of GCL in the retina by Pearson （r=-0.908，P=0.000）.Conclusion　The increase of serum Hcy level in diabetic patients is associated with the decrease of retinal GCL thickness，and Hcy is involved in neurodegenerative changes in patients with diabetic retinopathy.

参考文献/References:

［1］　JONSSON K B，FRYDKJAEROLSEN U，GRAUSLUND J.Vascular changes and neurodegeneration in the early stages of diabetic retinopathy：which comes first ［J］?Ophthalmic Res，2016，56（1）：1-9.
［2］　HUANG L L，YU J，ZHOU S X，WANG L，PENG Y，LIU X L，et al.Correlation analysis of Hcy and RBP4 with diabetic retinopathy［J］.Rec Adv Ophthalmol，2016，36（3）：244-246.
黄漓莉，于健，周素娴，王莉，彭鹰，刘晓玲，等.同型半胱氨酸和视黄醇结合蛋白4与糖尿病视网膜病变的相关性研究［J］.眼科新进展，2016，36（3）：244-246.
［3］　SHAMSUL O M，IMTIAZ N M，KHAN H A，ALHOMIDA A S.Neurodegeneration and neuroprotection in diabetic retinopathy［J］.Int J Mol Sci，2013，14（2）：2559-2572.
［4］　BRAZIONIS L，SR R K，ITSIOPOULOS C，HARPER C A，O’DEA K.Homocysteine and diabetic retinopathy［J］.Diabetes Care，2008，31（1）：50-56.
［5］　NAGGAR H，OLA M S，MOORE P，HUANG W，BRIDGES C C，GANAPATHY V，et al.Downregulation of reduced-folate transporter by glucose in cultured RPE cells and in RPE of diabetic mice［J］.Invest Ophthalmol Vis Sci，2002，43（2）：556-563.
［6］　HUANG E J，KUO W W，CHEN Y J，CHEN T H，CHANG M H，LU M C，et al.Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy［J］.Clin Chimica Acta，2006，366（1-2）：293-298.
［7］　LIM C P，LOO A V，KHAW K W，STHANESHWAR P，KHANG T F，HASSAN M，et al.Plasma，aqueous and vitreous homocysteine levels in proliferative diabetic retinopathy［J］.Br J Ophthalmol，2012，96（5）：704-707.
［8］　CORAL K，ANGAYARKANNI N，GOMATHY N，BHARATHSELVI M，PUKHRAJ R，RUPAK R.Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenousretinal detachment：its modulating role on lysyl oxidase［J］.Invest Ophthalmol Vis Sci，2009，50（8）：3607-3612.
［9］　POLOSCHEK C M，FOWLER B，UNSOLD R，LORENZ B.Disturbed visual system function in methionine synthase deficiency［J］.Graefes Arch Clin Exp Ophthalmol，2005，243（5）：497-500.
［10］　SRIVASTAV K，SAXENA S，MAHDI A A，SHUKLA R K，MEYER C H，AKDUMAN L，et al.Increased serum level of homocysteine correlates with retinal nerve fiber layer thickness in diabetic retinopathy［J］.Mol Vis，2016，22：1352-1360.
［11］　NG D S，CHIANG P P，TAN G，CHEUNG C G，CHENG C Y，CHEUNG C Y，et al.Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy［J］.Clin Exp Ophthalmol，2016，44（4）：243-250.
［12］　GANAPATHY P S，PERRY R L，TAWFIK A，SMITH R M，PERRY E，ROON P，et al.Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells［J］.Invest Ophthalmol Vis Sci，2011，52（8）：5551.
［13］　KERN T S，DU Y，MILLER C M，HATALA D A，LEVIN L A.Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy［J］.Am J Pathol，2010，176（5）：2550-2558.
［14］　ZWILLING D，HUANG S Y，SATHYASAIKUMAR K V.Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration［J］.Cell，2011，145（6）：863-874.
［15］　OLA M S，HOSOYA K，LANOUE K F.Regulation of glutamate metabolism by hydrocortisone and branched chain keto acids in cultured rat retinal müller cells（TR-MUL）［J］.Neurochem Int，2011，59（5）：656-663.
［16］　ZHANG Y M，BHAVNANI B R.Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor（AIF）and this process is inhibited by equine estrogens［J］.BMC Neurosci，2006，7（1）：1-22.
［17］　GANAPATHY P S，WHITE R E，HA Y，BOZARD B R，MCNEIL P L，CALDWELL R W，et al.The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinalganglion cells［J］.Invest Ophthalmol Vis Sci，2011，52（8）：5515-5524.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]黄漓莉,于健,周素娴,等.同型半胱氨酸和视黄醇结合蛋白4与糖尿病视网膜病变的相关性研究[J].眼科新进展,2016,36(3):244.[doi:10.13389/j.cnki.rao.2016.0065]
　HUANG Li-Li,YU Jian,ZHOU Su-Xian,et al.Correlation analysis of Hcy and RBP4 with diabetic retinopathy[J].Recent Advances in Ophthalmology,2016,36(6):244.[doi:10.13389/j.cnki.rao.2016.0065]
[12]徐卫星,徐军.糖尿病视网膜病变患者血清同型半胱氨酸、维生素B12及叶酸与氧化应激的关系[J].眼科新进展,2018,38(6):556.[doi:10.13389/j.cnki.rao.2018.0130]
　XU Wei-Xing,XU Jun.Correlation of serum homocysteine，vitamin B12 and folic acid with oxidative stress in patients with diabetic retinopathy[J].Recent Advances in Ophthalmology,2018,38(6):556.[doi:10.13389/j.cnki.rao.2018.0130]

备注/Memo

备注/Memo:
国家自然科学基金面上项目（编号：81372878）
更新日期/Last Update: 2018-07-10